ISIS-2503 is a 20-mer antisense oligonucleotide that inhibits Ha-Ras expression
References
[1] Adjei AA, Dy GK, Erlichman C, et al. A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.?Clin Cancer Res. 2003;9(1):115-123. PMID:12538459
